Validation of the MammaTyper (R) pathological complete response (pCR)-score as a predictor for response after neoadjuvant chemotherapy (NACT) in patients with early breast cancer (BC)
Fasching P, Laible M, Weber KE, Wirtz RM, Denkert C, Schlombs K, Schmatloch S, Camara O, Lueck HJ, Huober J, Karn T, Van Mackelenbergh MT, Marme F, Mueller V, Schem C, Stickeler E, Sahin U, Loibl S, Untch M (2018)
Publication Type: Conference contribution
Publication year: 2018
Journal
Publisher: OXFORD UNIV PRESS
City/Town: OXFORD
Pages Range: 53-53
Conference Proceedings Title: ANNALS OF ONCOLOGY
Event location: Munich, GERMANY
DOI: 10.1093/annonc/mdy269.166
Authors with CRIS profile
Involved external institutions
HELIOS Kliniken
Germany (DE)
Charité - Universitätsmedizin Berlin
Germany (DE)
STRATIFYER Molecular Pathology GmbH
Germany (DE)
BioNTech / Biopharmaceutical New Technologies
Germany (DE)
Krankenhaus Jerusalem
Germany (DE)
GBG Forschungs GmbH (German Breast Group)
Germany (DE)
Hufeland Klinikum
Germany (DE)
Universitätsklinikum Ulm
Germany (DE)
Universitätsklinikum Frankfurt am Main (KGU)
Germany (DE)
Universitätsklinikum Aachen (UKA)
Germany (DE)
Universitätsklinikum Schleswig-Holstein (UKSH)
Germany (DE)
Elisabeth-Krankenhaus Essen
Germany (DE)
Universitätsklinikum Hamburg-Eppendorf (UKE)
Germany (DE)
Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg
Germany (DE)
Germany (DE)
Charité - Universitätsmedizin Berlin
Germany (DE)
STRATIFYER Molecular Pathology GmbH
Germany (DE)
BioNTech / Biopharmaceutical New Technologies
Germany (DE)
Krankenhaus Jerusalem
Germany (DE)
GBG Forschungs GmbH (German Breast Group)
Germany (DE)
Hufeland Klinikum
Germany (DE)
Universitätsklinikum Ulm
Germany (DE)
Universitätsklinikum Frankfurt am Main (KGU)
Germany (DE)
Universitätsklinikum Aachen (UKA)
Germany (DE)
Universitätsklinikum Schleswig-Holstein (UKSH)
Germany (DE)
Elisabeth-Krankenhaus Essen
Germany (DE)
Universitätsklinikum Hamburg-Eppendorf (UKE)
Germany (DE)
Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg
Germany (DE)
How to cite
APA:
Fasching, P., Laible, M., Weber, K.E., Wirtz, R.M., Denkert, C., Schlombs, K.,... Untch, M. (2018). Validation of the MammaTyper (R) pathological complete response (pCR)-score as a predictor for response after neoadjuvant chemotherapy (NACT) in patients with early breast cancer (BC). In ANNALS OF ONCOLOGY (pp. 53-53). Munich, GERMANY: OXFORD: OXFORD UNIV PRESS.
MLA:
Fasching, Peter, et al. "Validation of the MammaTyper (R) pathological complete response (pCR)-score as a predictor for response after neoadjuvant chemotherapy (NACT) in patients with early breast cancer (BC)." Proceedings of the 43rd ESMO Congress (ESMO), Munich, GERMANY OXFORD: OXFORD UNIV PRESS, 2018. 53-53.
BibTeX: Download